• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

546.93 +8.22 (+1.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 202,818
Open 543.54
Bid (Size) 534.00 (120)
Ask (Size) 550.00 (40)
Prev. Close 538.71
Today's Range 537.10 - 551.45
52wk Range 393.61 - 615.00
Shares Outstanding 17,103,395
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Here's Exactly What It Will Take for Madrigal Pharmaceuticals Stock to Take Off ↗
August 25, 2026
Rezdiffra's biggest growth opportunity may still be ahead. 
Via The Motley Fool
News headline image
Madrigal’s Rezdiffra Hits $1.3B Run Rate as MASH Pipeline Expands ↗
August 15, 2026
Madrigal Pharmaceuticals (NASDAQ:MDGL) said Rezdiffra continued to post strong commercial growth in the second quarter of 2026, while the company expanded its development pipeline around the MASH... 
Via MarketBeat

Performance

YTD
-7.9%
-7.9%
1 Month
+13.5%
+13.5%
3 Month
+12.0%
+12.0%
6 Month
+25.8%
+25.8%
1 Year
+25.4%
+25.4%

More News

Read More
News headline image
Madrigal Pharmaceuticals Q2 Earnings Call Highlights ↗
July 30, 2026
Via MarketBeat
Topics Earnings
Madrigal Pharmaceuticals (NASDAQ:MDGL) Posts Q2 Beat Yet Shares Slide on Rezdiffra Ramp Worries ↗
July 30, 2026
Via Chartmill
Madrigal Pharmaceuticals (NASDAQ:MDGL) Shares Dip Despite Q1 2026 Earnings Beat and 127% Rezdiffra Revenue Growth ↗
May 06, 2026
Via Chartmill
Topics Earnings
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Reports Q4 2025 Revenue Beat and Significant EPS Miss ↗
February 19, 2026
Via Chartmill
News headline image
3 Under-the-Radar Stocks to Buy and Hold ↗
July 10, 2026
Via The Motley Fool
News headline image
3 Under-the-Radar Stocks to Buy and Hold for a Decade ↗
June 16, 2026
Via The Motley Fool
News headline image
Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800% ↗
May 29, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More ↗
May 29, 2026
Via The Motley Fool
News headline image
Arrowhead (ARWR) Q2 2026 Earnings Transcript ↗
May 08, 2026
Via The Motley Fool
News headline image
Madrigal (MDGL) Q1 2026 Earnings Transcript ↗
May 06, 2026
Via The Motley Fool
News headline image
3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist ↗
April 16, 2026
Via The Motley Fool
News headline image
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now ↗
March 25, 2026
Via The Motley Fool
News headline image
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story ↗
March 21, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗
March 21, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund ↗
March 20, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
2 Under-the-Radar Stocks to Buy and Hold ↗
March 10, 2026
Via The Motley Fool
News headline image
Madrigal (MDGL) Q4 2025 Earnings Call Transcript ↗
February 23, 2026
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year ↗
February 23, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50% ↗
February 23, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗
February 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗
February 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake ↗
February 17, 2026
Via The Motley Fool
News headline image
Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗
February 17, 2026
Via The Motley Fool

Frequently Asked Questions

Is Madrigal Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Madrigal Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Madrigal Pharmaceuticals, Inc. - Common Stock trade on?
Madrigal Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock is MDGL on the Nasdaq Stock Market
What is the current price of Madrigal Pharmaceuticals, Inc. - Common Stock?
The current price of Madrigal Pharmaceuticals, Inc. - Common Stock is 546.93
When was Madrigal Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Madrigal Pharmaceuticals, Inc. - Common Stock was at 09/02/26 04:00 PM ET
What is the market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock is 9.35B
How many shares of Madrigal Pharmaceuticals, Inc. - Common Stock are outstanding?
Madrigal Pharmaceuticals, Inc. - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap